Lausanne, Switzerland

Eric Fine

This inventor holds 1 USPTO granted patent. Top assignee: Cambridge Neuroscience, Inc.. Active years: 1997.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Eric Fine. Retrieved from https://idiyas.com/inventor/eric-fine

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 91(Granted Patents)


Company Filing History:


Years Active: 1997

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Eric Fine: Innovator in Therapeutic Delivery Systems

Introduction

Eric Fine is a notable inventor based in Lausanne, Switzerland. He has made significant contributions to the field of therapeutic delivery systems, focusing on optimizing the delivery of macromolecules to therapeutic targets.

Latest Patents

Eric Fine holds 1 patent for his invention titled "Device for delivery of substances and methods of use thereof." This invention comprises devices and methods for producing a composite microporous membrane specifically tailored to enhance the delivery of macromolecules.

Career Highlights

Eric Fine is currently associated with Cambridge Neuroscience, Inc., where he applies his expertise in developing innovative solutions for medical applications. His work is pivotal in advancing therapeutic delivery technologies.

Collaborations

He has collaborated with esteemed colleagues such as Stanley M. Goldin and Nagesh K. Mahanthappa, contributing to a dynamic research environment focused on groundbreaking innovations.

Conclusion

Eric Fine's work exemplifies the intersection of innovation and healthcare, showcasing the potential of advanced delivery systems in improving therapeutic outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…